| Rituximab Ineffective as Lupus Nephritis Add-On Therapy - Renal and Urology News |
|
|
Renal and Urology News As part of the Lupus Nephritis Assessment with Rituximab (LUNAR) trial, American and Mexican investigators led by Brad H. Rovin, MD, Director of Nephrology at the Ohio State College of Medicine in Columbus, Ohio, studied 144 patients (aged 16-75 years) |